Resolve™ is a clinical decision support platform that guides highly specific consumer interventions and provider engagement. Using dozens of data sources, including medical and pharmaceutical claims focus, the solution helps partners reduce unnecessary medical costs related to drug therapy problems. The solution is powered by QiLink™, a workflow tool bolstered by Stratify™ analytics, and that integrated with real-time consumer and provider input with national benchmark data, our analytics-guided real-time clinical decision support software. This advanced data-driven solution has over a decade of quantifiable outcomes bolstered by fully guaranteed value proposition.
By isolating the patient-specific gaps in care associated with each population, the value of each gap closure is evaluated within the population in order to identify savings associated with correcting the suboptimal use of medications.
Identifies and resolves medication adherence gaps
Improved care leads to better care and the associated medical savings
How We Make an Impact
REAL CONSUMER STORIES
Greg’s hospital discharge plan included new medications to treat his cholesterol. PharmMD’s analytics identified a high statin dosage and upon a discussion with our pharmacist, it became clear Greg was taking two statins prescribed by two physicians. Greg met with his doctor to resolve the error.
Ed has type 2 diabetes and is at risk for heart disease and/or stroke. PharmMD’s analytics identified a gap in statin usage for his diabetes and this prompted our nurse to reach out to Ed’s doctor. The doctor prescribed lovastatin to Ed and it addressed the quality issue.
Karen was taking two antidepressants and during a CMR, PharmMD’s analytics alerted our pharmacist to a potentially dangerous medication duplication. Our pharmacist discussed the issue with Karen and subsequently the consumer addressed the issue with her doctor. The doctor modified the regiment and improving her overall care plan.
David’s cholesterol medication refill was months overdue and during PharmMD’s CMR, he stated the discontinuation was due to receiving positive lab results. Our pharmacist convinced David the good lab results were a result of the medications, addressed the serious health risks with him and the consumer immediately refilled the medications.
Keith is in a long-term care center and was taking blood thinners warfarin and dabigatran as part of his daily regimen. PharmMD immediately contacted Keith's provider about the oversight. The provider agreed to discontinue one of the blood thinners. PharmMD's OptimizeMTM™ platform caught the therapy duplication preventing severe bleeding and other potentially life-threatening complications for this consumer.
Julie was taking a high-dosage of morphine for pain, but due to side-effects her physician changed medications to hydrocodone, oxycodone and acetaminophen. PharmMD analytics identified a acetaminophen dosage guideline issue, prompting our pharmacist to contact Julie’s physician to discuss alternatives and ultimately improved the chronic pain management.
Josh’s medication was changed from lisinopril to losartan for his hypertension. PharmMD analytics identified Josh hadn’t filled the lostaran which increased risk for stroke. Our clinician contacted Josh who was confused and followed up with his pharmacist and physician to close the gap.
Stephen was prescribed with lisinopril for high blood pressure but missed doses increasing risk for cardiac arrest. PharmMD’s analytics identified the risk and upon our clinician’s discussion with Stephen about his apparent memory issues, a pill organizer was facilitated ultimately improving adherence.
Roberta is 67 and her muscle pain was being treated with methocarbamol, which increases the risk of falling for consumers over 65 or older. PharmMD analytics identified tizanidine as a safer alternative, alerting our nurse to discuss the gap with Roberta’s clinician prompting a medication change.
Ida R. has type 2 diabetes and misunderstood how her insulin would regulate glucose release during the early dawn hours. PharmMD analytics identified insulin fill gaps that increased Ida's risk of complications and future hospitalizations. Upon our clinician intervening, Ida was educated about the importance of insulin and diabetes educational support. Ida returned to her prescribed care plan, improving her quality of care.
Mrs. Robbins’s heart disease requires simvastatin and clopidogrel to reduce heart attack and stroke risk. PharmMD’s medication adherence analytics prompted our pharmacist to discuss these risks. Mrs. Robbins supported the plan, improving quality and reducing her risk of hospitalization.
Margaret’s chronic asthma benefits from a rescue inhaler for flare-ups. PharmMD’s analytics showed a prescription gap and during PharmMD’s CMR discussion, our pharmacist discussed the issue with Margaret, prompting outreach to her doctor for an order to prevent asthma emergencies.
Carla struggled with high blood pressure and her losartan prescription was out of refills. PharmMD’s pharmacist reached out to Carla due to medication adherence analytics identifying medication gaps and subsequently contacted the physician for the refill order and improved quality of care.
Stratify™ predictive analytics identify medication adherence and care assessment gaps using comparative benchmarks that support targeted consumer and provider engagement.Learn More
Quantify™ builds actionable client-specific scenario modeling for value-based care incentive structures and incorporates Stratify™ analytics to achieve targeted outcomes.Learn More
P3Link™ is a regulatory compliant clinical workflow for Medication Therapy Management (MTM) that uses Stratify™ analytics to guide interventions.Learn More
QiLink™ is a clinical workflow using decision support to guide gap closure for clinical and non-clinical interventions with consumers and providers using Stratify™ analytics.Learn More
Discern™ is a business analytics solution that provides real-time client data visualization of outcomes and program performance.Learn More